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doi:10.1016/j.ejvs.2009.11.015Abstract Objective: To evaluate the usefulness of systematic coronary angiography
followed, if needed, by coronary artery angioplasty (percutaneous coronary intervention
(PCI)) on the incidence of cardiac ischaemic events after carotid endarterectomy (CEA) in
patients without evidence of coronary artery disease (CAD).
Materials and methods: From January 2005 to December 2008, 426 patients, candidates for
CEA, with no history of CAD and with normal cardiac ultrasound and electrocardiography
(ECG), were randomised into two groups. In group A (nZ 216) all the patients had coronary
angiography performed before CEA. In group B, all the patients had CEA without previous coro-
nary angiography. In group A, 66 patients presenting significant coronary artery lesions at angi-
ography received PCI before CEA. They subsequently underwent surgery under aspirin
(100 mg day1) and clopidogrel (75 mg day1). CEA was performed within a median delay of
4 days after PCI (range: 1e8 days).
Risk factors, indications for CEA and surgical techniques were comparable in both groups
(p> 0.05). The primary combined endpoint of the study was the incidence of postoperative
myocardial ischaemic events combined with the incidence of complications of coronaryXIII Annual Meeting 3e6 September, 2009, European Society for Vascular Surgery, Oslo, Norway.
o Bellini 14, 00198 Rome, Italy. Tel./fax: þ39 06 49 97 06 42.
niroma1.it (G. Illuminati).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
140 G. Illuminati et al.angiography. Secondary endpoints were death and stroke rates after CEA and incidence of
cervical haematoma.
Results: Postoperative mortality was 0% in group A and 0.9% in group B (pZ 0.24). One post-
operative stroke (0.5%) occurred in group A, and two (0.9%) in group B (pZ 0.62). No postop-
erative myocardial event was observed in group A, whereas nine ischaemic events were
observed in group B, including one fatal myocardial infarction (pZ 0.01). Binary logistic
regression analysis demonstrated that preoperative coronary angiography was the only inde-
pendent variable that predicted the occurrence of postoperative coronary ischaemia after
CEA. The odds ratio for coronary angiography (group A) indicated that when holding all other
variables constant, a patient having preoperative coronary angiography before carotid surgery
was 4 times less likely to have a cardiac ischaemic event after carotid surgery. No complica-
tions related to coronary angiography were observed and no cervical haematomas occurred
in patients undergoing surgery under aspirin and clopidogrel in this study.
Conclusions: Systematic preoperative coronary angiography, possibly followed by PCI, signifi-
cantly reduces the incidence of postoperative myocardial events after CEA in patients without
clinical evidence of CAD.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Patients with coronary artery disease (CAD) are at high risk
of postoperative myocardial complications.1,2 Given the
systemic nature of atherosclerosis, candidates for periph-
eral arterial reconstruction for obstructive disease have
a higher probability of having associated CAD than candi-
dates for nonvascular surgical intervention.3
Systematic preoperative coronary angiography in
peripheral vascular surgical candidates has already shown
the high prevalence of CAD in this population. Studies have
also shown the high sensitivity of coronary angiography
compared with other cardiac investigations, and the benefit
of coronary artery bypass grafting (CABG) before peripheral
revascularisation.3,4 The results of these studies, together
with the improvement of coronary artery catheterisation
technique, and the contemporary availability of coronary
stenting over CABG could theoretically support the perfor-
mance of coronary angiography, and possibly stenting, as
part of the standard preoperative protocol for patients
scheduled to undergo peripheral arterial revascularisation.
Nonetheless, disparate opinions exist concerning the indi-
cations for coronary angiography and coronary revascular-
isation before elective peripheral vascular surgery.5
In addition, even if some studies have shown the safety and
efficacy of coronary angiography and revascularisation in
preventing postoperative cardiac events in non-cardiac sur-
gery,6e9 other reports have failed to demonstrate the benefit
of such an aggressive preoperative protocol, with the risk of
operativebleedingdue to theaspirin andclopidogrel regimen,
which is required when performing coronary stenting.1,10e13
One possible explanation of these contradictory results
may be the inclusion of non-comparable groups of patients,
with differing preoperative cardiac status and risk factors. To
avoid this problem, in this study, we randomised all patients
scheduled to undergo an elective carotid endarterectomy
(CEA) without any clinical history or electrical signs of
ischaemic heart disease. In group A, all patients had coronary
angiography, followed, if needed, by coronary angioplasty
with stenting. Patients randomised to group B received
a standard cardiac evaluation before endarterectomy. Our
hypothesis was that, in patients with a significant carotid
stenosis even without any history of CAD, systematic preop-
erativecoronaryangiography followed, ifneeded,bycoronarystenting could significantly improve the postoperative cardiac
outcome after CEA, as compared with patients receiving
a standard preoperative cardiac evaluation.
Methods
Study design
This randomised trial was conducted at two academic
surgical centres and in one affiliated surgical service. The
trial was supported by a grant from the University of Rome.
The institutional review board of the University approved
the trial protocol and all patients provided written
informed consent. Random assignment of patients to the
two treatment groups was done independently of partici-
pating centres in a one-to-one ratio. The randomisation
sequence was generated by a computer program and
supplied to centres using sealed opaque envelopes gener-
ated in blocks of six.
Selection of patients
Patients referred for CEA were eligible for enrollment if
they had no apparent evidence of CAD, defined as the
absence of any clinical sign or history of ischaemic cardiac
disease, associated with the absence of electrical signs of
cardiac ischaemia at rest and with a left ventricular ejec-
tion fraction >50% at trans-thoracic echocardiogram.
Patients suspected of having coronary disease or dyspnoea;
patients with previous events of myocardial ischaemia or
previously treated either with percutaneous coronary
intervention (PCI) or with coronary artery bypass grafting
(CABG); or patients with other cardiac dysfunctions,
including arrhythmias, were excluded from the study.
After determination of eligibility for the trial, including
a standard preoperative cardiac evaluation, patients were
randomly assigned either to undergo CEA (group B) or to
complete this evaluation with coronary angiography
followed, if needed, by PCI prior to CEA (group A).
In group A, coronary arteries, as seen on angiography,
were considered abnormal if they had one or more coronary
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decision was made following a multidisciplinary discussion
between the interventional cardiologist, the cardiac surgeon
and the vascular surgeon in charge of the patient.
PCI always involved angioplasty and stenting.
During the stenting procedure, all patients received an
intravenous bolus of tirofiban followed by a dual oral anti-
platelet drug regimen, consisting of 100 mg of aspirin and
75 mgof clopidogrel daily. This treatmentwas continued until
themorningof scheduledCEA,and resumedtheeveningof the
operation. CEA was performed with a mean delay of 4 days
after PCI (extremes 1e8 days). After PCI, and after CEA, all
patients had a continuous ECG performed for 24 h, and their
serumtroponinconcentrationwasassessedat 4, 8,12and24 h
after the procedure. Patients requiring CABG underwent
combined CEA and CABG during the same hospitalisation.
Before CEA, patients in both groups received atorvas-
tatin. In addition, 141 patients (65%) in group A, and 152
(72%) in group B received beta-blocking drugs. In group B,
all patients received 100 mg of aspirin, starting at least 1
week before CEA.
The indications for CEA included carotid artery stenosis
>60% according to the North American Symptomatic
Carotid Endarterectomy Trial (NASCET) criteria,14 either
asymptomatic or symptomatic. Carotid endarterectomy
was performed under general anaesthesia, with trans-
cutaneous cerebral oxymetry monitoring (INVOS 5100C,
Somanetics, Troy, MI, USA). The surgical technique con-
sisted of either an eversion endarterectomy or an endar-
terectomy with a polyester patch closure. Indications for
shunting were a recent stroke, occlusion of the contralat-
eral internal carotid artery or a significant decrease of
ispsilateral cerebral hemisphere oxygenation after clamp-
ing of the carotid bifurcation. Cervical drainage was
routinely left in place and removed the day after surgery.
Before clamping, all patients received 50 IU kg1 of
heparin, which was not reversed by protamine at the end of
the procedure. After carotid revascularisation, all patients
were admitted to the recovery room for 4e5 h. In the
absence of complications, they returned to the ward within
24 h, and were discharged 3 days after surgery.Primary endpoint
The primary combined endpoint of the study was the
occurrence of any postoperative myocardial ischaemic
event, combined with any complication related to coronary
angiography and stenting.
The occurrence of an ischaemic myocardial event was
defined as any electrical abnormality on the ECG suggestive
of ischaemia associated with an elevation of serum troponin
level, associated or not with clinical symptoms.
Electrical signs consistent with myocardial ischaemia
included S-T segment depression or elevation and T-wave
inversion. Postoperative deaths either associated with any
modification of the above-mentioned cardiac parameters,
or with the detection of recent areas of ischaemia at
myocardial post-mortem examination, were considered to
be due to myocardial infarction.
Results of PCI were analysed in intention to treat. Fail-
ures to perform the planned PCI, or residual stenosis ofmore than 20% after coronary PCI were considered as
a failure of the procedure. The site of arterial puncture was
assessed for haematoma, thrombosis or other complica-
tions. These events were considered as complications of PCI
if they required surgical treatment.
Secondary endpoint
Secondary endpoint included death and stroke rates, cranial
nerve palsy and cervical haematoma. Cervical haematomas
were recorded only if they required surgical evacuation.
Statistical analysis
The study was designed with a power of 80% to detect
differences in primary outcome in 200 patients per group,
with a two-sided alpha of 0.05, on the basis of a 5%difference
in the incidence of postoperative coronary events after CEA
in patients with coronary angiography compared with
patients without coronary angiography. Proportions were
compared using the chi-square and Fisher’s exact tests.
Binary logistic regression analysis with SPSS was used to
measure the effects of binary risk factors on postoperative
cardiac ischaemic events whilst adjusting for inter-rela-
tionships between them. The output is presented with the
coefficient and statistics of the variables that have been
included in the model and the constant, with calculation of
the B value that represents the change in the outcome
resulting from a unit change in the predictor variable. The
Wald statistic, which has a chi-square distribution, reflects
whether the B coefficient for that predictor was signifi-
cantly different from zero. The Hosmer and Lemeshow test
was also computed for this model as a chi-square to ensure
that the data fit the model well.
Results
From January 2005 to December 2008, 426 patients were
enrolled in the study. Among these, 216 were randomised
to undergo preoperative coronary angiography (group A)
prior to CEA, and 210 underwent CEA without prior coronary
angiography (group B). No significant differences between
the two study groups were observed concerning demog-
raphy or risk factors (Table 1).
In group A, 68 patients (31%) had a significant stenosis of
the coronary arteries. Sixty-six patients underwent treat-
ment with PCI and two with CABG. The pattern of the
coronary lesions and details of treatment are summarised in
Table 2. PCI was performed with a median delay of 4 days
(range: 1e8 days) before CEA and always consisted of
angioplasty and stenting. In general, 94 coronary artery
stents were deployed, with 82 drug-eluting stents and 12
bare stents. Forty-three patients (65%) received one stent
and 23 patients (35%) more than one. Indications for carotid
surgery and details of surgical technique were comparable
in both groups (Table 3).
Primary endpoint
No postoperative myocardial ischaemic event occurred in
group A, whereas nine ischaemic events were observed in
Table 1 Demography and risk factors.
Baseline
characteristics
Group A Group B p Value
NZ 216 NZ 210
Mean age (yrs) SD 77 7 74 7 0.79
Men (%) 65 68 0.60
Hypertension (%) 76 80 0.90
Smokers (%) 40 43 0.62
Hyperlipidemia (%) 29 26 0.52







Demography and risk factors in Group A (patients with preop-
erative coronary angiography prior to carotid surgery) and in
Group B (patients not having coronary angiography prior to
carotid surgery). Differences among the two groups were not
statistically significant.
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fatal myocardial infarction extending to the septum, and
eight cases of non-fatal coronary ischaemia with electrical
and enzymatic alterations that could be managed by an
appropriate medical treatment. These eight patients had
a coronary angiography within 2e6 weeks after carotid
surgery followed by a successful PCI in five patients with,
respectively, one single-vessel, one double-vessel, one left
main and two triple-vessel coronary lesions. CABG was
performed in one patient with left main coronary artery
disease. The remaining two patients had coronary lesions
with extensive triple-vessel disease including occlusion of
tributaries not amenable to coronary revascularisation.
Using univariate analysis, smokers and patients in group
B not having preoperative coronary angiography had
a higher risk of a postoperative coronary ischaemic event
(Table 4). Binary logistic regression analysis was used to
confirm the relationship between predictor variables and
postoperative cardiac ischaemia. As shown in Table 5,
preoperative coronary angiography was the only indepen-
dent variable that was significantly correlated with the
occurrence of postoperative coronary ischaemia after CEA.
The odds ratio for the patients in group A indicates that,Table 2 Coronary lesions in patients (Group A).
Coronary lesions Patients PCI CABG
N (%) N (%) N (%)
Single-vessel disease 43 (64) 43 (64) e
Double-vessel disease 19 (28) 19 (28) e
Triple-vessel disease 3 (4) 2 (2.5) 1 (1.5)
Left main disease 3 (4) 2 (2.5) 1 (1.5)
Total 68 (100) 66 (97) 2 (3)
Pattern of asymptomatic coronary lesions seen at coronary
angiography in 68 patients (Group A). These lesions were
treated before carotid surgery by coronary angioplasty and
stenting (PCI) in 66 patients and by coronary bypass (CABG) in 2
patients.when keeping all other variables constant, patients having
coronary angiography before carotid surgery were 4 times
less likely to have a cardiac ischaemic event after carotid
surgery. In this series, no patients having preoperative
coronary angiography followed, when positive, by PCI or
CABG, had a postoperative cardiac ischaemic event. In
addition, no complication related to coronary angiography
or to PCI occurred in this series.
Secondary endpoint
Concerning survival, two patients died during the post-
operative period, one from myocardial infarction and the
other from stroke. Both deaths occurred in group B (0.9%).
There was no mortality in group A (pZ 0.24).
The 30-day postoperative death and stroke rate
(Table 6) was 0.5% in group A and 1.8% in group B (two
strokes, including one fatal stroke and one death following
myocardial infarction) (pZ 0.36). No cervical haematoma
requiring re-operation was observed in either group.
Discussion
The goal of this study was to assess the value of systematic
preoperative coronary angiography prior to CEA to prevent
postoperative myocardial ischaemic events in patients with
a normal ECG and normal cardiac echography and without
any history of coronary ischaemia. Our findings support the
hypothesis that performing preoperative coronary angiog-
raphy followed, if needed, by PCI prior to CEA, significantly
reduces the incidence of postoperative cardiac ischaemic
events without any added morbidity. The optimal cardiac
evaluation before peripheral vascular surgery and major
non-cardiac surgery remains a matter of debate. Numerous
studies have yielded contradictory results, and, overall,
they failed to demonstrate the real benefit of systematic
coronary angiography in the preoperative cardiac work-up
of these patients.1,10e12 Several reasons may have
contributed to these inconclusive results: in particular,
differences in patient selection, whereby patients with
different stages of CAD were included; type of peripheral
bypass considered; and the evolution of medical devices for
PCI, including catheters and stents.
As the incidence of significant asymptomatic CAD in
patients with peripheral arterial disease is well known,15e17
we thought that it would be interesting to discover if treating
significant, although asymptomatic, CAD ahead of a periph-
eral arterial revascularisation was a valuable option.
To obtain a homogeneous clinical trial, this randomised
study was deliberately restricted to patients undergoing
CEA with no history or evidence of CAD. These patients
were enrolled at three centres performing CEA with
comparable surgical and anaesthesiological protocols. This
decision was taken to avoid major differences in PCI and
CEA technique and competence that may have biased the
results. Nevertheless, subjecting asymptomatic coronary
patients even with significant coronary stenosis to PCI may
be considered more risk than profit for the patient, espe-
cially when dealing with single- and double-vessel disease,
without left main equivalent disease. However, in the
present study, two out of eight patients in group B
Table 3 Carotid endarterectomy. Indications and technique.
Group A Group B Odds ratio (95%CI) p Value
NZ 216 (%) NZ 210 (%)
Indications for carotid surgery
Asymptomatic 157 (72) 151 (71) 1.04 (0.68e1.59) 0.91
Transient ischaemic attack 46 (22) 50 (24) 0.87 (0.55e1.36) 0.56
Stroke 13 (6) 9 (4) 1.43 (0.59e3.42) 0.51
Operative technique
CEA with patch closure 177 (82) 176 (84) 0.87 (0.53e1.45) 0.69
CEA (eversion) 39 (18) 34 (16)
Carotid shunt 26 (12) 19 (9) 1.45 (0.77e2.70) 0.27
Duration of operation (minutes SD) 123 21 127 12 0.82
Preoperative bleeding (mL SD) 126 42 112 36 0.78
Indications for carotid surgery and operative surgical techniques were comparable in both groups. CEA: carotid endarterectomy,
SD: standard deviation.
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actually had single-vessel disease (one patient) and double-
vessel disease (one patient), which were successfully
treated by PCI. Surgery probably triggered the symptoms
and led to treatment in these two patients who would
otherwise have experienced symptoms and coronary
complications later in life. It can be speculated that, in this
group of patients, preoperative PCI can prevent post-
operative ischaemia and eventually protect patients from
later coronary ischaemic events.
Patients with PCI received dual anti-platelet treatment
with aspirin and clopidogrel that cannot be discontinued for
at least 6 months after PCI. In this setting, patents under-
going CEA may be considered at risk of postoperative
bleeding. This gives rise to the problem of either delaying
CEA, with the consequent risk of stroke, or operating early
on patients receiving dual anti-platelet treatment. We have
shown in this study, as others,18e22 that CEA can be per-
formed safely within a week of PCI in patients receiving
dual anti-platelet treatment. No major bleeding or cervical
haematomas, and no coronary stent thromboses were
observed in this series. In addition, obtaining a perfect
haemostasis of the surgical field at the end of CEA was not
more demanding and did not significantly lengthen theTable 4 Effects of risk factors and of preoperative coronar
ischaemic event. Univariate analysis.
Odds ratio
Male vs female 0.75
Hyperlipidemia vs none 0.86
Diabetes vs none 2.28
Hypertension vs none 1.14
Lower limb occlusive disease vs
none
2.68
Smoker vs non-smoker 2.98
Coronary angiography vs none 0.23
With Univariate Analysis (Pearson’s Chi-Square and Fisher’s Exact Tes
postoperative cardiac ischaemia. Smokers had a three-fold increase
coronary angiography (group A) followed possibly by coronary reva
myocardial ischaemia.duration of CEA, when compared with CEA performed in
patients receiving only aspirin (Table 3).
Previous studies have shown the beneficial effect of
postoperative beta-blocker therapy and of statins in
reducing the risk of myocardial ischaemic events in major
non-cardiac surgery and in vascular surgery.23e25 This study
did not address the issue of whether optimal postoperative
medical treatment could equal coronary revascularisation
in reducing the risk of postoperative ischaemic myocardial
events. However, given that this study was randomised and
that all the patients received statins, anti-platelet drugs
and a consistent number of them in both groups were
receiving beta-blockers, it is clear that coronary angiog-
raphy followed, if needed, by PCI seems to allow better
protection from myocardial ischaemic events than statins,
anti-platelet agents and beta-blockers alone. Patients
having PCI received clopidogrel in addition to aspirin, and,
compared with other patients, this might be considered
a potential bias. We recognised this potential limitation
from the beginning of the trial; nonetheless, we thought
that it would have been unethical to expose all the patients
of both groups to the potential bleeding risks of dual anti-
platelet treatment, assuming that dual treatment and
statins would have little difference in impact on coronaryy angiography on the occurrence of postoperative cardiac








t), two variables were significantly correlated with the onset of
of postoperative cardiac ischaemia and patients randomised to
scularization were 4 times less likely to sustain postoperative
Table 5 Postoperative cardiac ischaemic events. Results of logistic regression analysis.
B SE Wald test p Value Odds ratio Odds ratio [95% CI]
Age (<75 yrs) vs (75 yrs) 0.22 0.03 0.38 0.53 0.98 0.92e1.04
Male vs female 0.35 0.56 0.41 0.52 0.70 0.24e2.08
Hyperlipidemia vs none 0.01 0.61 0.00 0.99 1.00 0.30e3.35
Diabetes vs none 0.89 0.56 2.48 0.12 2.44 0.80e7.42
Hypertension vs none 0.21 0.68 0.09 0.76 1.23 0.32e4.69
LLOD vs none 1.18 0.71 2.71 0.10 3.25 0.79e13.2
Smoker vs non-smoker 1.01 0.57 3.14 0.08 2.74 0.89 -8.36
Coronary angiography vs none 1.51 0.66 5.16 0.02 0.22 0.06e0.81
Constant 2.04 2.75 0.55 0.46 0.13
Results of the multivariate analysis using binary logistic regression. Postoperative coronary ischaemia was the dependent variable.
Among all the independent variables that were analysed in this model, preoperative coronary angiography was the only variable to have
a significant impact on the occurrence of a postoperative cardiac ischaemic event with an odds ratio of 0.22.
LLOD: Lower Limb Occlusive Disease. CI: Confidence Interval, B: Regression coefficient. SE: Standard Error of B.
As part of the logistic regression model provided by SPSS, the Hosmer and Lemeshow test was computed as a Chi-Square comparing the
observed frequencies with those expected under the linear model. The Chi-Square was equal to 2.47 with dfZ 8 giving a p valueZ 0.96,
indicating that the data fit the model well.
144 G. Illuminati et al.artery disease stabilisation compared with single anti-
platelet treatment and statins. A further randomised trial
comparing patients with PCI and dual anti-platelet regimen
versus patients with dual anti-platelet regimen alone for
treating asymptomatic coronary artery lesions could
specifically address this important issue.
This study did not address the issue of the efficacy of
systematic coronary angiography and eventual PCI or CABG
on late survival in patients undergoing CEA. Although the
COURAGE trial26 has shown that optimal medical treatment
is equivalent to PCI for the treatment of stable coronary
disease, the limited use of drug-eluting stents and patient-
selection bias in the COURAGE trial do not allow for the
exclusion of the potential benefit of optimal coronary
revascularisation together with best medical treatment in
patients having asymptomatic but significant coronary
artery disease discovered at the time of CEA. Considering
other studies that failed to demonstrate a substantial
benefit of coronary artery revascularisation over the best
medical treatment in patients undergoing aortic surgery,
the same comments may apply since they exclude patients
with common trunk coronary lesions, use mainly bare stents
and discontinue anti-platelet drugs before surgery.12
In conclusion, our study demonstrates the potential
benefit of systematic coronary angiography, followed, if
needed, by PCI, in patients with significant but asymp-
tomatic coronary artery disease before CEA. We recognise,
however, that our results, coming from a relatively small
randomised study, should be confirmed by larger trials that
should include a long-term follow-up to analyse theTable 6 Postoperative complications of carotid surgery.
Group A Group B p Value
NZ 216 NZ 210
30-Day death rate 0 2 (0.9%) 0.24
30-Day stroke rate 1 (0.5%) 2 (0.9%) 0.62
30-Day death
and stroke rate
1 (0.5%) 3 (1.8%) 0.36
Cervical haematoma 0 0 epotential impact of this aggressive approach on survival and
freedom from long-term coronary events.
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